Your browser doesn't support javascript.
loading
Pre-operative tumour marker status predicts recurrence and survival after complete cytoreduction and hyperthermic intraperitoneal chemotherapy for appendiceal Pseudomyxoma Peritonei: Analysis of 519 patients.
Taflampas, P; Dayal, S; Chandrakumaran, K; Mohamed, F; Cecil, T D; Moran, B J.
Affiliation
  • Taflampas P; Peritoneal Malignancy Department, Basingstoke and North Hampshire Hospitals, UK. Electronic address: taflampas2003@yahoo.gr.
  • Dayal S; Peritoneal Malignancy Department, Basingstoke and North Hampshire Hospitals, UK.
  • Chandrakumaran K; Peritoneal Malignancy Department, Basingstoke and North Hampshire Hospitals, UK.
  • Mohamed F; Peritoneal Malignancy Department, Basingstoke and North Hampshire Hospitals, UK.
  • Cecil TD; Peritoneal Malignancy Department, Basingstoke and North Hampshire Hospitals, UK.
  • Moran BJ; Peritoneal Malignancy Department, Basingstoke and North Hampshire Hospitals, UK.
Eur J Surg Oncol ; 40(5): 515-520, 2014 May.
Article in En | MEDLINE | ID: mdl-24462284
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Appendiceal Neoplasms / Peritoneal Neoplasms / Pseudomyxoma Peritonei / Carcinoembryonic Antigen / Biomarkers, Tumor / CA-19-9 Antigen / CA-125 Antigen / Neoplasm Recurrence, Local Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Eur J Surg Oncol Year: 2014 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Appendiceal Neoplasms / Peritoneal Neoplasms / Pseudomyxoma Peritonei / Carcinoembryonic Antigen / Biomarkers, Tumor / CA-19-9 Antigen / CA-125 Antigen / Neoplasm Recurrence, Local Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Eur J Surg Oncol Year: 2014 Type: Article